Navigation Links
Rockefeller University Press allows authors to retain copyright to their published work
Date:5/2/2008

Citing the growing demand from the public and the scientific community for access to research data, The Rockefeller University Press has revised its copyright policy to allow authors to retain the rights to work published in its three journals. The policy, which became effective May 1, applies to all three Rockefeller University Press journals: The Journal of Cell Biology, The Journal of Experimental Medicine and The Journal of General Physiology.

The new policy allows authors to reuse their published work in any way and provides for third-party reuse under the terms of a Creative Commons license, say Mike Rossner, executive director of the press, and Emma Hill, executive editor of The Journal of Cell Biology. Hill and Rossner lay out the terms of the new policy in an editorial published in the May issues of all three journals.

Under the terms of the policy, authors may reuse their published work for any purpose, including commercial profit, as long as each use includes attribution to the original publication. Third parties can reuse and redistribute work published in Rockefeller University Press journals, without permission, for any noncommercial purpose, with the same requirement for attribution that applies to authors.

The new policy breaks with common practice among scientific publishers, the vast majority of which require authors to relinquish copyright to the publisher in full as a condition of publication. The press, which now retains licenses from its authors instead of copyright, made its first move toward policy reversal in July 2000, when it gave authors the right to post their articles on their own Web sites immediately after publication. Since January, 2001, the press has released all of its content to the public six months after publication, but permission was still required for any reuse beyond self-archiving.

Our copyright and public-access policies simply acknowledge who did the work and who paid for it to be
'/>"/>

Contact: Joseph Bonner
bonnerj@rockefeller.edu
212-327-8998
Rockefeller University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Rockefeller University hosts 2-day evolution symposium, May 1-2, 2008
2. Cummings School receives Rockefeller Foundation grant
3. Montana State University research reaches Supreme Court of India
4. BP funds scholarship for University of Houston to help fill industry ranks
5. Energy Crossroads conference April 30 and May 1 at Stanford University
6. McMaster University engineering professor receives Humboldt Research Award
7. UTMB inventions win University of Texas System commercialization awards
8. University of Arizona scientist shares in discovery of microbe filaments power
9. Flowers fragrance diminished by air pollution, University of Virginia study indicates
10. Pitt and University of Chicago researchers uncover process behind heart muscle contraction
11. Yale Universitys Strobel recognized for work on RNA

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ELPHIA, NOVEMBER 9, 2009 A nutritionist whose re...ables to the federal Women, Infants and Children (...Agnes Higgins Award for outstanding achievement in... Harrison, Ph.D., MNS, , a professor in the Depart...y of California, Los Angeles School of Public Heal...
(Date:11/8/2009)...STON - (Nov. 8, 2009) The loss of a gene through ...ssociated with significant abnormalities in learni...led by Baylor College of Medicine ( www.bcm.edu ) ...al Nature Genetics . , "This research goes abou...in a specific group of individuals to this gene," ...
(Date:11/6/2009)...X, Va.Registration is now open for the Society of ...ional Oncology (IO) Therapies" Webinar, which will...anscatheter treatment of liver tumors, kidney tumo...nal organization of physicians, scientists and all...blic health through pioneering advances in image-g...
Breaking Biology News(10 mins):March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Developmental delay could stem from nicotinic receptor deletion 2Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 1Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 3Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 4Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 1Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 2Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 3Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 4Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 1Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 2Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 3
...ce penicillin, a byproduct of a fungal mold, was d...gi for other breakthrough drugs. As reported Jan....m led by a University of Wisconsin-Madison researc...ongoing quest for medically useful compounds in fu...the team, led by professor of plant pathology and ...
...ence is emerging that climate change could reduce ...lso international efforts to cut poverty. However,...dy providing researchers with some of the tools th...oid the worst effects of the problem. , The new kn...wing scientists to both develop new rice varieties...
... 2005 may have been the warmest year in a century,... data from around the world. , Climatologists at N...n New York City noted that the highest global annu...ury was recorded in their analysis for the 2005 ca...udy climate change rank 2005 as the second warmest...
Other Biology News:Mining for gems in the fungal genome 2Mining for gems in the fungal genome 3Climate change: The rice genome to the rescue 2Climate change: The rice genome to the rescue 32005 was the warmest year in a century 2
(Date:11/9/2009)...ewswire-Asia/ -- The pharma and biotech sectors ar...anies are facing significant,pressure to change wi... calls for,lower prices and a greater regulatory b...l crisis have made the work of creating new drugs ... being forced to globalize their R&D,operation...
(Date:11/9/2009)...RNewswire/ -- Following the provision of clinical,...stration (FDA), privately,owned UK company Daval I...al.com ) has been informed that its innovative,ant...n Orphan-Drug,designation for the treatment of Amy...also known as Lou Gehrig,s disease, is the most co...
(Date:11/6/2009)...RNewswire-FirstCall/ -- BioSpecifics Technologies ...y developing first-in-class collagenase-based prod...e third quarter ended September 30, 2009. ,, "... year, the FDA,s Arthritis Advisory Committee unan...al of XIAFLEX(TM) for the treatment of Dupuytren,s...
(Date:11/6/2009)...v. 6 Calbiotech, Inc. announced to...vative Research (SBIR) Phase I contract by the U.S...r terms of the agreement, Calbiotech will develop ... of Dengue virus. ,, Dengue virus is a mosqu... to military forces deployed to tropical areas of ...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in Shanghai 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2
...NAPOLIS, and CAMBRIDGE, Mass., May 5 Amylin Pha...nd Company (NYSE: LLY ) and Alkermes, Inc. (Nasd...cation (NDA) for exenatide once weekly has been su...FDA). Exenatide once weekly is an investigational ...hat is injected subcutaneously and administered on...
...SCO, Calif., May 5 Rigel Pharmaceuticals, Inc. (N...or the first quarter ended March 31, 2009. , , Fo...loss of $29.9 million, or $0.82 per share, compare...re, in the first quarter of 2008. Weighted average... and 2008 were 36.7 million and 34.4 million, resp...
...hallenges separate haves and have-nots and acceler... Despite worldwide economic turmoil, the global b...performance in 2008, according to Beyond borders:...ung,s 23rd annual report on the biotech industry. ...t is placing the business model that fueled biotec...
Other Biology Technology:Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 2Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 3Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 4Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 5Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 6Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 7Rigel Announces First Quarter 2009 Financial Results 2Rigel Announces First Quarter 2009 Financial Results 3Rigel Announces First Quarter 2009 Financial Results 4Rigel Announces First Quarter 2009 Financial Results 5Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young 2Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young 3Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young 4
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
...ct measuring instrument for calibrating single-cha...ompact design and the robust carrying case, the MC... laboratory and on-site at the users premises. The...ual channels are tested automatically. Multi-chann...
...tol DTT White solid.. PACKAGED UNDER INERT GAS. ...action is "driven" to completion. A protective age... found in many other preparations. Blocks the leth... ≥97% by titration. Contaminants: Heavy metal...
Biology Products: